ICG
( DrugBank: - / KEGG DRUG: - )
3 diseases
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
93 | Primary biliary cholangitis | 1 |
94 | Primary sclerosing cholangitis | 1 |
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
235 | Hypoparathyroidism | 3 |
93. Primary biliary cholangitis
Clinical trials : 352 / Drugs : 206 - (DrugBank : 55) / Drug target genes : 40 - Drug target pathways : 119
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
94. Primary sclerosing cholangitis
Clinical trials : 177 / Drugs : 120 - (DrugBank : 48) / Drug target genes : 25 - Drug target pathways : 148
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
235. Hypoparathyroidism
Clinical trials : 100 / Drugs : 103 - (DrugBank : 27) / Drug target genes : 5 - Drug target pathways : 7
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|